human fibrinogen / human thrombin
Evarrest : EPAR - Summary for the public (PDF/514.84 KB)
First published: 07/10/2013
Last updated: 03/04/2018
|Agency product number||
|International non-proprietary name (INN) or common name||
|Therapeutic area (MeSH)||
|Anatomical therapeutic chemical (ATC) code||
Omrix Biopharmaceuticals N. V.
|Date of issue of marketing authorisation valid throughout the European Union||
Leonardo Da Vinci Laan 15
15/11/2017 Evarrest - EMEA/H/C/002515 - II/0027/G
This medicine’s product information is available in all official EU languages.
Select ‘available languages’ to access the language you need.
Product information documents contain:
- summary of product characteristics (annex I);
- manufacturing authorisation holder responsible for batch release (annex IIA);
- conditions of the marketing authorisation (annex IIB);
- labelling (annex IIIA);
- package leaflet (annex IIIB).
You can find product information documents for centrally authorised human medicines on this website. For centrally authorised veterinary medicines authorised or updated from February 2022, see the Veterinary Medicines Information website.
Supportive treatment in adult surgery where standard surgical techniques are insufficient (see section 5.1):
- for improvement of haemostasis.